These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 17019711)
1. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711 [TBL] [Abstract][Full Text] [Related]
2. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800 [TBL] [Abstract][Full Text] [Related]
3. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522 [TBL] [Abstract][Full Text] [Related]
4. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328 [TBL] [Abstract][Full Text] [Related]
5. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. Meng CF; Zhu XJ; Peng G; Dai DQ Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243 [TBL] [Abstract][Full Text] [Related]
6. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
8. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735 [TBL] [Abstract][Full Text] [Related]
9. Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis. Wu Y; Meng L; Wang H; Xu Q; Wang S; Wu S; Xi L; Zhao Y; Zhou J; Xu G; Lu Y; Ma D Oncol Rep; 2006 Sep; 16(3):625-9. PubMed ID: 16865265 [TBL] [Abstract][Full Text] [Related]
10. Fhit, a tumor suppressor protein, induces autophagy via 14-3-3τ in non-small cell lung cancer cells. Lee TG; Jeong EH; Kim SY; Kim HR; Kim H; Kim CH Oncotarget; 2017 May; 8(19):31923-31937. PubMed ID: 28404875 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer. Zhong S; Fields CR; Su N; Pan YX; Robertson KD Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657 [TBL] [Abstract][Full Text] [Related]
13. Promoter methylation status of tumor suppressor genes and inhibition of expression of DNA methyltransferase 1 in non-small cell lung cancer. Liu B; Song J; Luan J; Sun X; Bai J; Wang H; Li A; Zhang L; Feng X; Du Z Exp Biol Med (Maywood); 2016 Aug; 241(14):1531-9. PubMed ID: 27190263 [TBL] [Abstract][Full Text] [Related]
14. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. Tang XX; Robinson ME; Riceberg JS; Kim DY; Kung B; Titus TB; Hayashi S; Flake AW; Carpentieri D; Ikegaki N Clin Cancer Res; 2004 Sep; 10(17):5837-44. PubMed ID: 15355914 [TBL] [Abstract][Full Text] [Related]
15. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland. Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354 [TBL] [Abstract][Full Text] [Related]
16. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features. Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452 [TBL] [Abstract][Full Text] [Related]
17. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas. Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576 [TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood. Tan S; Sun C; Wei X; Li Y; Wu Y; Yan Z; Feng F; Wang J; Wu Y Exp Lung Res; 2013; 39(4-5):182-90. PubMed ID: 23614702 [TBL] [Abstract][Full Text] [Related]
19. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells]. Fang HL; Yu ZC; Zhu HB; Jin YT Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. Heller G; Schmidt WM; Ziegler B; Holzer S; Müllauer L; Bilban M; Zielinski CC; Drach J; Zöchbauer-Müller S Cancer Res; 2008 Jan; 68(1):44-54. PubMed ID: 18172295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]